Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p13
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 13/51)
Character Range: 35031–37882

Repeats: 2]
(a) insert in numerical order in the column headed "Circumstances": C16305 C16338 C16339 C16340
(b) insert in numerical order in the column headed "Purposes": P16305 P16338 P16339 P16340
[77] Schedule 1, Part 1, entries for Siponimod
substitute:
Siponimod  Tablet 250 micrograms (as hemifumarate)  Oral  Mayzent  NV  MP NP  C16303 C16347  P16303 P16347  12   0     12
Siponimod  Tablet 250 micrograms (as hemifumarate)  Oral  Mayzent  NV  MP NP  C16303 C16347  P16303 P16347  120  5     120
Siponimod  Tablet 1 mg (as hemifumarate)            Oral  Mayzent  NV  MP NP  C16303 C16347                 28   5     28
Siponimod  Tablet 2 mg (as hemifumarate)            Oral  Mayzent  NV  MP NP  C16303 C16347                 28   5     28

[78] Schedule 1, Part 1, entries for Sumatriptan
omit:
Sumatriptan  Nasal spray 20 mg in 0.1 mL single dose unit  Nasal  Imigran  AS  MP NP  C5259     2  5     2

[79] Schedule 1, Part 1, entries for Tenecteplase
omit:
Tenecteplase  Powder for injection 40 mg with solvent  Injection  Metalyse  BY  MP NP  C5783     1  0     1

[80] Schedule 1, Part 1, entries for Teriflunomide
(a) omit from the column headed "Authorised Prescriber" (all instances): MP substitute (all instances): MP NP
(b) omit from the column headed "Circumstances" (all instances): C10150 C10199 substitute (all instances): C16315 C16323
[81] Schedule 1, Part 1, entries for Timolol
omit:
Timolol  Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL (S19A)  Application to the eye  Timoptol XE 0.50% (South Africa)  LM  MP AO        1  5     1

[82] Schedule 1, Part 1, after entry for Ursodeoxycholic acid in the form Capsule 250 mg [Brand: Ursosan]
insert:
Ursodeoxycholic acid  Capsule 500 mg  Oral  Ursodox GH  GQ  MP NP  C9032     100  4     100

[83] Schedule 1, Part 2, omit entry for Budesonide with formoterol
[84] Schedule 1, Part 2, omit entry for Triglycerides, long chain with glucose polymer
[85] Schedule 3,
omit:
NI  Novo Nordisk Pharmaceuticals Pty. Limited  40 002 879 996

[86] Schedule 3, after entry for Responsible Person code UC
insert:
UI  PERRIGO AUSTRALIA PTY LIMITED  15 141 623 403

[87] Schedule 4, Part 1, omit entry for Circumstances Code "C6860"
[88] Schedule 4, Part 1, omit entry for Circumstances Code "C7695"
[89] Schedule 4, Part 1, omit entry for Circumstances Code "C10093"
[90] Schedule 4, Part 1, omit entry for Circumstances Code "C10139"
[91] Schedule 4, Part 1, omit entry for Circumstances Code "C10140"
[92] Schedule 4, Part 1, omit entry for Circumstances Code "C10150"
[93] Schedule 4, Part 1, omit entry for Circumstances Code "C10162"
[94] Schedule 4, Part 1, omit entry for Circumstances Code "P10170"
[95] Schedule 4, Part 1, omit entry for Circumstances Code "C10171"
[96] Schedule 4, Part 1, omit entry for Circumstances Code "C10172"
[97] Schedule 4, Part 1, omit